US Critical Metals Corp
USCM
Mydecine Innovations Group Inc
MYCO
Three Valley Copper Corp
TVC.H
Tuga Innovations Inc
TUGA
Windfall Geotek Inc
WIN
CA Stock MarketDetailed Quotes
RHT.H Reliq Health Technologies Inc
- 0.215
- 0.0000.00%
15min DelayMarket Closed Jan 16 15:59 ET
42.30MMarket Cap-10238P/E (TTM)
0.000High0.000Low0Volume0.000Open0.215Pre Close0.00Turnover0.00052wk High0.00%Turnover Ratio196.76MShares0.00052wk Low-0.021EPS TTM42.30MFloat Cap0.000Historical HighLossP/E (Static)196.76MShs Float0.000Historical Low-0.04EPS LYR0.00%Amplitude--Dividend TTM5.12P/B1Lot Size--Div YieldTTM
Reliq Health Technologies Inc Key Stats
Quarterly+Annual
YOY
| (Q1)Sep 30, 2022 | (FY)Jun 30, 2022 | (Q4)Jun 30, 2022 | (Q3)Mar 31, 2022 | (Q2)Dec 31, 2021 | (Q1)Sep 30, 2021 | (FY)Jun 30, 2021 | (Q4)Jun 30, 2021 | (Q3)Mar 31, 2021 | (Q2)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 38.89%-1.33M | -12.97%-8.03M | 17.89%-1.61M | 16.92%-1.47M | -12.39%-2.77M | -137.85%-2.18M | -13.57%-7.11M | -85.23%-1.96M | -16.79%-1.76M | 1.56%-2.47M |
| Net income from continuing operations | 97.09%-122.48K | 30.64%-8.17M | 55.59%-994.9K | 70.70%-811.04K | 49.42%-2.16M | -67.61%-4.21M | -5.92%-11.78M | -26.79%-2.24M | 3.02%-2.77M | -6.07%-4.26M |
| Operating gains losses | -2,503.87%-13.46K | ---7.58K | ---9.14K | ---125 | --2.2K | ---517 | ---- | ---- | ---- | ---- |
| Depreciation and amortization | 3.10%27.76K | -8.32%115.29K | -22.89%34.9K | 12.43%26.66K | -7.55%26.8K | -3.12%26.93K | -71.77%125.76K | 152.51%45.26K | -88.13%23.72K | -82.20%28.99K |
| Remuneration paid in stock | -83.11%710.5K | 26.26%5.51M | -112.18%-521.3K | 103.31%112.39K | -31.99%1.71M | 339.82%4.21M | 16.28%4.36M | 1,730.95%4.28M | -427.17%-3.39M | 41.00%2.52M |
| Other non cashItems | -42.86%5.66K | -24.32%35.28K | -134.07%-34.81K | 107.84%8.11K | 120.11%52.07K | -96.77%9.91K | 28.81%46.62K | 320.95%102.16K | -1,010.08%-103.4K | -58,275.96%-258.88K |
| Change In working capital | 12.32%-1.94M | -3,030.94%-5.47M | -104.85%-46.58K | -30.20%-801.78K | -217.40%-2.41M | -468.20%-2.21M | -75.45%186.7K | 65.37%960.21K | -743.61%-615.83K | -113.74%-759.1K |
| -Change in receivables | -124.04%-3.92M | -547.08%-7.32M | -280.79%-1.71M | -387.24%-1.96M | -860.42%-1.9M | -2,031.55%-1.75M | -136.01%-1.13M | -374.07%-449.46K | -79.35%-402.03K | -6.55%-197.92K |
| -Change in inventory | -116.77%-54.62K | -50.09%273.29K | 7,843.26%349.38K | -306.35%-519.05K | -39.51%117.25K | 205.28%325.71K | -43.47%547.56K | -100.50%-4.51K | --251.54K | --193.85K |
| -Change in prepaid assets | 78.24%-74.65K | 188.77%41.95K | -305.84%-481.66K | 423.27%704.8K | 351.11%161.91K | -27,702.74%-343.1K | -167.48%-47.26K | 3,342,757.14%234K | -2,461.81%-218.02K | -68.49%-64.48K |
| -Change in payables and accrued expense | 572.78%2.11M | 87.61%1.53M | 52.28%1.8M | 492.77%971.36K | -14.06%-787.66K | -177.54%-446.31K | 183.07%817.94K | 631.07%1.18M | -179.62%-247.31K | -426.68%-690.55K |
| Interest paid (cash flow from operating activities) | ---- | 24.32%-35.28K | ---- | ---- | ---- | ---- | -89.68%-46.62K | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 38.89%-1.33M | -12.97%-8.03M | 14.36%-1.61M | 21.84%-1.47M | -1.40%-2.77M | -252.26%-2.18M | -13.57%-7.11M | -77.62%-1.88M | -24.14%-1.88M | -9.12%-2.73M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0 | 0 | -93.82%23K | 0 | 0 | 0 | ||||
| Net investment purchase and sale | ---- | --0 | --0 | ---- | ---- | ---- | --23K | --0 | --0 | --0 |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | --0 | --0 | --0 | ---- | ---- | --0 | -93.82%23K | --0 | --0 | --0 |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -61.36%1.28M | 8.74%7.93M | -43.45%949.73K | 125.49%3M | -79.66%684.42K | 258.00%3.3M | 31.40%7.3M | 62.64%1.68M | 8.90%1.33M | 51.52%3.37M |
| Net issuance payments of debt | 40.98%-21.12K | 18.94%-97.73K | 141.24%8.22K | -13.48%-35.14K | -0.50%-35.03K | -2.75%-35.79K | -1,446.17%-120.57K | -140.57%-19.93K | 10.31%-30.96K | -211.28%-34.85K |
| Net common stock issuance | ---- | --0 | --0 | ---- | ---- | ---- | --3.04M | --0 | --48.78K | ---- |
| Proceeds from stock option exercised by employees | -61.14%1.3M | 77.74%7.89M | -34.00%1.05M | 88.63%2.78M | 74.35%719.45K | 248.71%3.34M | -20.18%4.44M | 62.25%1.6M | 17.29%1.47M | -81.51%412.64K |
| Net other financing activities | ---- | 352.36%144K | -207.68%-111.68K | ---1.06M | ---2.68M | --3.99M | ---57.06K | --103.71K | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -82.51%1.28M | 8.74%7.93M | -43.45%949.73K | 26.93%1.69M | -159.42%-2M | 691.13%7.3M | 31.40%7.3M | 62.64%1.68M | 8.90%1.33M | 51.52%3.37M |
| Net cash flow | ||||||||||
| Beginning cash position | -41.32%132.78K | 1,668.10%226.3K | 86.59%790.16K | -41.37%568.13K | 3,216.79%1.35M | 1,668.10%226.3K | -96.29%12.8K | 42.36%423.48K | 261.67%968.99K | -84.24%40.59K |
| Current changes in cash | -105.15%-57.72K | -143.80%-93.52K | -233.39%-657.37K | 140.70%222.03K | -183.81%-778.06K | 3,930.11%1.12M | 164.26%213.5K | 30.74%-197.18K | -1,945.77%-545.52K | 8,784.28%928.41K |
| End cash Position | -94.42%75.07K | -41.32%132.78K | -41.32%132.78K | 86.59%790.16K | -41.37%568.13K | 3,216.79%1.35M | 1,668.10%226.3K | 1,668.10%226.3K | 42.36%423.48K | 261.67%968.99K |
| Free cash from | 38.89%-1.33M | -12.97%-8.03M | 14.36%-1.61M | 21.84%-1.47M | -1.40%-2.77M | -252.26%-2.18M | -12.66%-7.11M | -69.56%-1.88M | -24.14%-1.88M | -9.12%-2.73M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.